Institute of Genetics & Cancer: Obesity Drug Heart Benefits Not Just Due to Weight Loss
September 25, 2026
September 25, 2026
EDINBURGH, Scotland, Sept. 25 (TNSjou) -- The University of Edinburgh College of Medicine and Veterinary Medicine - Institute of Genetics and Cancer issued the following news:
* * *
Obesity drug heart benefits not just due to weight loss
The reduced risk of heart disease seen in people who are overweight or have obesity taking the weight loss drug semaglutide may not be due to a drop in weight alone, a study shows.
Researchers examined known ri . . .
* * *
Obesity drug heart benefits not just due to weight loss
The reduced risk of heart disease seen in people who are overweight or have obesity taking the weight loss drug semaglutide may not be due to a drop in weight alone, a study shows.
Researchers examined known ri . . .
